Insider Stock Trading History of Deerfield Special Situations Fund, L.p.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Deerfield Special Situations Fund, L.p. since year 2005. The trader's CIK number is 1354395. At the time of this reporting, Deerfield Special Situations Fund, L.p. is the of Recro Pharma, Inc. . (stock ticker symbol REPH). See this page for all insider trading activities at Recro Pharma, Inc. .

Note that in the past Deerfield Special Situations Fund, L.P. also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Deerfield Special Situations Fund, L.p. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-06-12 REPH Recro Pharma, Inc. Sale 10,000 6.74 67,400
2017-06-13 REPH Recro Pharma, Inc. Sale 32,447 6.59 213,825
2017-06-14 REPH Recro Pharma, Inc. Sale 68,000 6.25 425,000
2017-06-07 REPH Recro Pharma, Inc. Sale 45,623 7.09 323,467
2017-06-08 REPH Recro Pharma, Inc. Sale 17,245 6.99 120,542
2017-01-24 CASM Cas Medical Systems Inc Sale 47,320 1.50 71,074
2017-01-25 CASM Cas Medical Systems Inc Sale 71,468 1.50 107,202
2017-01-26 CASM Cas Medical Systems Inc Sale 517,450 1.46 752,889
2017-01-23 CASM Cas Medical Systems Inc Sale 86,691 1.47 127,002
2017-01-20 CASM Cas Medical Systems Inc Sale 46,522 1.53 71,271
2017-01-19 CASM Cas Medical Systems Inc Sale 71,913 1.60 115,060
2016-12-13 IVTY Invuity, Inc. Sale 71,173 6.13 436,148
2016-12-14 IVTY Invuity, Inc. Sale 45,568 6.01 273,681
2016-12-12 IVTY Invuity, Inc. Sale 68,055 6.45 439,090
2016-09-22 VNDA Vanda Pharmaceuticals Inc. Sale 340,964 16.24 5,536,914
2016-09-23 VNDA Vanda Pharmaceuticals Inc. Sale 779,497 16.71 13,023,056
2016-09-19 VNDA Vanda Pharmaceuticals Inc. Sale 45,811 15.54 712,131
2016-09-15 VNDA Vanda Pharmaceuticals Inc. Sale 201,703 15.76 3,177,830
2016-09-16 VNDA Vanda Pharmaceuticals Inc. Sale 300,372 15.62 4,691,510
2016-07-20 ZFGN Zafgen, Inc. Sale 1,341,499 3.31 4,443,044
2016-07-21 AXGN Lectec Corp /mn/ Sale 102,136 6.70 684,311
2016-07-14 AXGN Lectec Corp /mn/ Sale 206,090 7.70 1,586,893
2016-07-15 AXGN Lectec Corp /mn/ Sale 31,788 7.32 232,688
2016-07-18 AXGN Lectec Corp /mn/ Sale 41,425 6.87 284,589
2016-02-12 ZFGN Zafgen, Inc. Buy 64,545 6.25 403,212
2016-01-20 XNPT Xenoport Inc Buy 346,417 4.09 1,418,577
2015-12-16 VNDA Vanda Pharmaceuticals Inc. Buy 11,170 8.97 100,161
2015-12-17 STRM Lanvision Systems Inc Sale 226,000 1.20 271,878
2015-12-16 STRM Lanvision Systems Inc Sale 116,464 1.23 142,784
2015-12-15 STRM Lanvision Systems Inc Sale 54,795 1.34 73,480
2015-12-11 VNDA Vanda Pharmaceuticals Inc. Buy 322,872 8.61 2,779,605
2015-12-09 VNDA Vanda Pharmaceuticals Inc. Buy 775,382 8.61 6,672,937
2015-12-10 VNDA Vanda Pharmaceuticals Inc. Buy 103,110 8.59 885,714
2015-09-30 ATRS Antares Pharma Inc Sale 249,998 1.69 422,996
2015-09-29 ATRS Antares Pharma Inc Sale 225,048 1.82 409,362
2015-09-28 ATRS Antares Pharma Inc Sale 1,353,483 1.81 2,447,097
2015-09-18 AXGN Lectec Corp /mn/ Sale 345,000 5.50 1,897,845
2015-04-08 AXGN Lectec Corp /mn/ Sale 144,385 3.25 469,251
2015-02-18 NVTA Invitae Corp Buy 175,000 16.00 2,800,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Deerfield Special Situations Fund, L.p. ( of Recro Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.